BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21290536)

  • 1. Implantation of post-translational tyrosylprotein sulfation into a prokaryotic expression system.
    Lu LY; Chen BH; Wu JY; Wang CC; Chen DH; Yang YS
    Chembiochem; 2011 Feb; 12(3):377-9. PubMed ID: 21290536
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression, purification and crystallization of human 3'-phosphoadenosine-5'-phosphosulfate synthetase 1.
    Harjes S; Scheidig A; Bayer P
    Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):350-2. PubMed ID: 14747722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the substrate recognition mechanism of ATP-sulfurylase domain of human PAPS synthase 2.
    Zhang P; Zhang L; Hou Z; Lin H; Gao H; Zhang L
    Biochem Biophys Res Commun; 2022 Jan; 586():1-7. PubMed ID: 34818583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational modification of protein by tyrosine sulfation: active sulfate PAPS is the essential substrate for this modification.
    Suiko M; Fernando PH; Sakakibara Y; Nakajima H; Liu MC; Abe S; Nakatsu S
    Nucleic Acids Symp Ser; 1992; (27):183-4. PubMed ID: 1289811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under-sulfation by PAPS synthetase inhibition modulates the expression of ECM molecules during chondrogenesis.
    Cho YR; Lee SJ; Jeon HB; Park ZY; Chun JS; Yoo YJ
    Biochem Biophys Res Commun; 2004 Oct; 323(3):769-75. PubMed ID: 15381066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1.
    Mueller JW; Idkowiak J; Gesteira TF; Vallet C; Hardman R; van den Boom J; Dhir V; Knauer SK; Rosta E; Arlt W
    J Biol Chem; 2018 Jun; 293(25):9724-9735. PubMed ID: 29743239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation.
    Xu Z; Wood TC; Adjei AA; Weinshilboum RM
    Drug Metab Dispos; 2001 Feb; 29(2):172-8. PubMed ID: 11159808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Screening of Sulfated Proteins by Using a Genome-Wide Proteome Microarray and Protein Tyrosine Sulfation System.
    Huang BY; Chen PC; Chen BH; Wang CC; Liu HF; Chen YZ; Chen CS; Yang YS
    Anal Chem; 2017 Mar; 89(6):3278-3284. PubMed ID: 28211678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfation of tert-butoxycarbonylcholecystokinin and other peptides by rat liver tyrosylprotein sulfotransferase.
    Rens-Domiano S; Hortin GL; Roth JA
    Mol Pharmacol; 1989 Oct; 36(4):647-53. PubMed ID: 2811860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosylprotein sulfotransferase activity is increased in human gastric mucosa of alcoholics.
    Sundaram P; Slomiany BL; Slomiany A; Rajiyah G; Khan MY; Kasinathan C
    Am J Gastroenterol; 1992 Oct; 87(10):1460-3. PubMed ID: 1415104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins.
    Ouyang Yb; Lane WS; Moore KL
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2896-901. PubMed ID: 9501187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification.
    Saini SP; Sonoda J; Xu L; Toma D; Uppal H; Mu Y; Ren S; Moore DD; Evans RM; Xie W
    Mol Pharmacol; 2004 Feb; 65(2):292-300. PubMed ID: 14742670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential enzymatic characteristics and tissue-specific expression of human TPST-1 and TPST-2.
    Mishiro E; Sakakibara Y; Liu MC; Suiko M
    J Biochem; 2006 Nov; 140(5):731-7. PubMed ID: 17028309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential roles of 3'-phosphoadenosine 5'-phosphosulfate synthase in embryonic and larval development of the nematode Caenorhabditis elegans.
    Dejima K; Seko A; Yamashita K; Gengyo-Ando K; Mitani S; Izumikawa T; Kitagawa H; Sugahara K; Mizuguchi S; Nomura K
    J Biol Chem; 2006 Apr; 281(16):11431-40. PubMed ID: 16497669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of human PAPS synthetase 1 reveals asymmetry in substrate binding.
    Harjes S; Bayer P; Scheidig AJ
    J Mol Biol; 2005 Apr; 347(3):623-35. PubMed ID: 15755455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency.
    Venkatachalam KV
    IUBMB Life; 2003 Jan; 55(1):1-11. PubMed ID: 12716056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Phosphoadenosine 5'-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding.
    van den Boom J; Heider D; Martin SR; Pastore A; Mueller JW
    J Biol Chem; 2012 May; 287(21):17645-17655. PubMed ID: 22451673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric kinetic analysis of human tyrosylprotein sulfotransferase-1 and -2.
    Danan LM; Yu Z; Hoffhines AJ; Moore KL; Leary JA
    J Am Soc Mass Spectrom; 2008 Oct; 19(10):1459-66. PubMed ID: 18672380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating PAPSS2 mutations in a patient with premature pubarche.
    Noordam C; Dhir V; McNelis JC; Schlereth F; Hanley NA; Krone N; Smeitink JA; Smeets R; Sweep FC; Claahsen-van der Grinten HL; Arlt W
    N Engl J Med; 2009 May; 360(22):2310-8. PubMed ID: 19474428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonation and molecular action.
    Strott CA
    Endocr Rev; 2002 Oct; 23(5):703-32. PubMed ID: 12372849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.